NHS National Pharmaceuticals - Everolimus and terminated agreement products

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1
Sector
HEALTH
Published
28 Sep 2021
Delivery
not specified
Deadline
n/a

Related Terms

Location

United Kingdom: Please refer to document 03, schedule 8 in the ITO documents for the list of Purchasing Points

Geochart for 1 buyers and 45 suppliers

1 buyer

15 suppliers

Description

Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022

Lot Division

1 CM/PHG/21/5632/00 Everolimus

Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632/00Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
2 CM/PHG/21/5632/01 Oral (plus non parenteral) products

Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
3 CM/PHG/21/5632/02 Hospital Only products

Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Award Detail

1 Selective Supplies (London)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-1
  • Value: £1
2 Drreddys Laboratories (Beverley)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-2
  • Value: £1
3 Bristol Laboratories (Berkhamsted)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-3
  • Value: £1
4 Drugsrus (Northwood)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-4
  • Value: £1
5 Bowmed Ibisqus (Manchester)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-5
  • Value: £1
6 Martindale Pharma (Romford)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-6
  • Value: £1
7 Milpharm (South Ruislip)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-7
  • Value: £1
8 Teva (Castleford)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-8
  • Value: £1
9 Crescent Pharma (Basingstoke)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-9
  • Value: £1
10 Fresenius Kabi (Runcorn)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-10
  • Value: £1
11 Ranbaxy (Hayes)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-11
  • Value: £1
12 Mylan (Potters Bar)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-12
  • Value: £1
13 Accord (Barnstaple)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-13
  • Value: £1
14 Medreich (Weybridge)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-14
  • Value: £1
15 Torrent Pharma (Crawley)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/01-15
  • Value: £1
16 Selective Supplies (London)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-16
  • Value: £1
17 Drreddys Laboratories (Beverley)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-17
  • Value: £1
18 Bristol Laboratories (Berkhamsted)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-18
  • Value: £1
19 Drugsrus (Northwood)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-19
  • Value: £1
20 Bowmed Ibisqus (Manchester)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-20
  • Value: £1
21 Martindale Pharma (Romford)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-21
  • Value: £1
22 Milpharm (South Ruislip)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-22
  • Value: £1
23 Teva (Castleford)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-23
  • Value: £1
24 Crescent Pharma (Basingstoke)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-24
  • Value: £1
25 Fresenius Kabi (Runcorn)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-25
  • Value: £1
26 Ranbaxy (Hayes)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-26
  • Value: £1
27 Mylan (Potters Bar)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-27
  • Value: £1
28 Accord (Barnstaple)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-28
  • Value: £1
29 Medreich (Weybridge)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-29
  • Value: £1
30 Torrent Pharma (Crawley)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/00-30
  • Value: £1
31 Selective Supplies (London)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-31
  • Value: £1
32 Drreddys Laboratories (Beverley)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-32
  • Value: £1
33 Bristol Laboratories (Berkhamsted)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-33
  • Value: £1
34 Drugsrus (Northwood)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-34
  • Value: £1
35 Bowmed Ibisqus (Manchester)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-35
  • Value: £1
36 Martindale Pharma (Romford)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-36
  • Value: £1
37 Milpharm (South Ruislip)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-37
  • Value: £1
38 Teva (Castleford)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-38
  • Value: £1
39 Crescent Pharma (Basingstoke)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-39
  • Value: £1
40 Fresenius Kabi (Runcorn)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-40
  • Value: £1
41 Ranbaxy (Hayes)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-41
  • Value: £1
42 Mylan (Potters Bar)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-42
  • Value: £1
43 Accord (Barnstaple)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-43
  • Value: £1
44 Medreich (Weybridge)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-44
  • Value: £1
45 Torrent Pharma (Crawley)
  • NHS National Pharmaceuticals - Everolimus and terminated agreement products
  • Reference: 024061-2021-cm/phg/21/5632/02-45
  • Value: £1

Renewal Options

Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-02a471
  • FTS 024061-2021

Domains